Possible to use them for regenerative therapies, repairing damaged organs or tissues in the body, and treating conditions such as type I diabetes or liver disease
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.
Using the technique, researchers have for the first time been able to grow a pure, self-renewing population of stem cells specific to the human foregut, the upper section of the human digestive system.
These so-called “Foregut stem cells” could then be developed further to produce liver or pancreatic cells. The method significantly improves on existing techniques for cultivating this type of stem cell, and raises the possibility that, with further work, they could be grown in large numbers in bioreactors. That would make it possible to use them for regenerative therapies, repairing damaged organs or tissues in the body, and treating conditions such as type I diabetes or liver disease.
“We have developed a cell culture system which allows us to specifically isolate foregut stem cells in the lab,” Dr Nicholas Hannan, from the University of Cambridge Wellcome Trust MRC Stem Cell Institute, Department of Surgery, explained. Hannan led the study, which was carried out in the lab of Dr Ludovic Vallier.
“These cells have huge implications for regenerative medicine, because they are the precursors to the thyroid upper airways, lungs, liver, pancreas, stomach and biliary systems. We now have a system where we may be able to create all these cell types from the same starting population.”
As reported in the journal Stem Cell Reports, the method also means that researchers will be able to analyse the embryonic development of foregut cells in greater depth. “We now have a platform from which we can study the early patterning events that occur during human development to produce the intestines, liver, lungs and pancreas,” Hannan added.
The approach marks a breakthrough because it overcomes some of the problems which currently limit scientists’ abilities to grow cells associated with the liver, pancreas, and other parts of the foregut in sufficiently large numbers for clinical use.
Stem cell growth starts with human pluripotent stem cells (hPSCs). These are non-specialised biological cells with the potential to transform – or “differentiate” – into any of the three primary layers of cells from which all tissues and organs develop. Because these cells also self-renew, creating copies of themselves, they offer the potential to provide an infinite source of clinically usable cells for regenerative medicine.
Go deeper with Bing News on:
Transplant therapies
- Gilead's Flagship CAR T-cell Therapy Shows Improved Overall Survival In Pretreated Lymphoma Patients
Kite, a Gilead Science Inc (NASDAQ: GILD) company, announced the primary overall survival (OS) analysis results of the Phase 3 ZUMA-7 study. The results showed a statistically significant improvement ...
- A woman with a paralyzed arm had movement completely restored after a delicate nerve transplant
A 45-year-old woman couldn't lift her arm after getting surgery to remove compressed discs in her neck. A nerve transfer helped her recover.
- TEER or VAD/Transplant in the Advanced HF Patient With MR?
In a THT 2023 debate, a 57-year-old with severe HF was the jumping off point for discussing what’s gained or lost with TEER.
- Soiffer Discusses Relapse After Transplant
Robert J. Soiffer, MD, discusses the role of transplantation and relapse after transplant for patients with cancer.
- RG6501 (OpRegen®) Phase 1/2a Clinical Results to Be Presented at 2023 Retinal Cell and Gene Therapy Innovation Summit
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that results from a ...
Go deeper with Google Headlines on:
Transplant therapies
[google_news title=”” keyword=”Transplant therapies” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Regenerative medicine
- Leading Regenerative Medicine Practitioner, On How Stem Cell Can Help In the Treatment of Autism
His journey on this path began with his wife, Christine (Chris Weiss), after the birth of their son, Marston, who was diagnosed with autism.
- The Alliance for Regenerative Medicine Appoints Rita Johnson-Greene as Chief Operating Officer
Washington, D.C., March 21, 2023 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic ...
- 2023 Regenerative Medicine Market Competition Analysis: Assessing Success and Failure
Final Report will add an analysis of the impact of the Russia-Ukraine War and COVID-19 on theRegenerative Medicine industry. Regenerative Medicine Market report has been divided into different ...
- Discover Regenerative Medicine Solutions and Viable Alternatives to Surgery at QC Kinetix (Columbia Downtown)
Fortunately, regenerative medicine offers non-invasive hair loss treatments that can help to rehabilitate follicles and improve their health and productivity. Individuals seeking effective and natural ...
- Regenerative Medicine Market Size and Forecast till 2028
What is the Regenerative Medicine market growth? Regenerative Medicine Market Size is projected to Reach Multimillion USD by 2028, In comparison to 2023, at unexpected CAGR during the forecast Period ...
Go deeper with Google Headlines on:
Regenerative medicine
[google_news title=”” keyword=”regenerative medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]